GT Metabolic Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $45M

  • Investors
  • 5

GT Metabolic General Information

Description

Developer of a gastrointestinal device system designed to perform a minimally invasive procedure in the field of gastroenterology. The company's system can be used for medical procedures by creating a magnetic connection in the gastrointestinal tract, enabling medical professionals with a potentially less invasive approach compared to traditional surgical methods.

Contact Information

Website
www.gtmetabolic.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3050 Three Springs Court
  • San Jose, CA 95140
  • United States
+1 (626)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Vertical(s)
HealthTech
Corporate Office
  • 3050 Three Springs Court
  • San Jose, CA 95140
  • United States
+1 (626)

GT Metabolic Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GT Metabolic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 28-Oct-2026 $45M Completed Generating Revenue
2. Later Stage VC (Series B) 15-Dec-2025 Completed Generating Revenue
1. Early Stage VC (Series A) 30-Jan-2023 $18.6M $18.6M Completed Generating Revenue
To view GT Metabolic’s complete valuation and funding history, request access »

GT Metabolic Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C3
Series C2
Series C1
Series B
Series A-1 762,853 $0.001000 $3.91 $3.91 1x $3.91 4.37%
Series A 2,984,364 $0.001000 $5.22 $5.22 1x $5.22 17.09%
To view GT Metabolic’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

GT Metabolic Patents

  • 98

    Total Documents Applications and Grants

  • Total Patents Families

  • 61

    Granted

  • 24

    Pending

  • Expiring in next 12 mo

GT Metabolic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260114871-A1 Robotically-assisted delivery and positioning of magnetic implants for forming an anastomosis Pending 04-Apr-2024
WO-2025212795-A1 Robotically-assisted delivery and positioning of magnetic implants for forming an anastomosis Pending 04-Apr-2024
US-12622698-B2 System and method for retrieving a magnetic implant for forming an anastamosis in the digestive tract Active 13-Nov-2023
US-20250152172-A1 System and method for retrieving a magnetic implant for forming an anastamosis in the digestive tract Active 13-Nov-2023
EP-4808458-A1 System and method for retrieving a magnetic implant for forming an anastomosis in the digestive tract Pending 13-Nov-2023 A61B17/1114
To view GT Metabolic’s complete patent history, request access »

GT Metabolic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GT Metabolic Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
JPMorgan Life Sciences Private Capital Venture Capital Minority
AB Medica PE-Backed Company Minority
Ceros Financial Services Other Minority
HealthTech Capital Angel Group Minority
Krillion Ventures Venture Capital Minority
To view GT Metabolic’s complete investors history, request access »

Ready to get started?

Request a free trial

GT Metabolic FAQs

  • When was GT Metabolic founded?

    GT Metabolic was founded in 2020.

  • Where is GT Metabolic headquartered?

    GT Metabolic is headquartered in San Jose, CA.

  • What is the size of GT Metabolic?

    GT Metabolic has 27 total employees.

  • What industry is GT Metabolic in?

    GT Metabolic’s primary industry is Surgical Devices.

  • Is GT Metabolic a private or public company?

    GT Metabolic is a Private company.

  • What is the current valuation of GT Metabolic?

    The current valuation of GT Metabolic is .

  • What is GT Metabolic’s current revenue?

    The current revenue for GT Metabolic is .

  • How much funding has GT Metabolic raised over time?

    GT Metabolic has raised $91.5M.

  • Who are GT Metabolic’s investors?

    JPMorgan Life Sciences Private Capital, AB Medica, Ceros Financial Services, HealthTech Capital, and Krillion Ventures have invested in GT Metabolic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process